These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social. Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200 [No Abstract] [Full Text] [Related]
7. [Fetomaternal microtransfusion in different labor course]. Steffen U; Husstedt WD; Meyenberg H Med Klin; 1970 Nov; 65(45):1967-9. PubMed ID: 4999596 [No Abstract] [Full Text] [Related]
8. An antenatal evaluation of increased RH-antibody stimulation. Vos GH S Afr Med J; 1969 Feb; 43(6):130-2. PubMed ID: 4975795 [No Abstract] [Full Text] [Related]
9. [Studies on the demonstration of fetal erythrocytes in the maternal blood during the postpartum period]. Cordier P; Madeline P; Guillaumin JP; Jeanney JC; Couzineau P Ann Biol Clin (Paris); 1967; 25(7):903-11. PubMed ID: 4965531 [No Abstract] [Full Text] [Related]
10. [Practical questions in the immunological prevention of Rh sensitization]. Althoff W; Schellong G; Stahl M Munch Med Wochenschr; 1969 Jun; 111(25):1386-95. PubMed ID: 4185511 [No Abstract] [Full Text] [Related]
11. The pathogenesis and prevention of Rh immunization. Zipursky A; Israels LG Can Med Assoc J; 1967 Nov; 97(21):1245-57. PubMed ID: 4168032 [No Abstract] [Full Text] [Related]
12. Suppression of Rh isoimmunization. A review. Bowman JM Obstet Gynecol; 1978 Oct; 52(4):385-93. PubMed ID: 101918 [No Abstract] [Full Text] [Related]
13. [Practical problems of preventing Rh sensitization using immunological methods]. Althoff W; Schellong G; Stahl M Rev Clin Esp; 1969 Sep; 114(6):515-24. PubMed ID: 4988856 [No Abstract] [Full Text] [Related]
14. [Status of Rh sensitization prevention in the Federal Republic of Germany]. Stolp W; Schlenter W; Schneider J Geburtshilfe Frauenheilkd; 1972 Sep; 32(9):762-72. PubMed ID: 4116752 [No Abstract] [Full Text] [Related]
15. [Demonstration and elimination of HbF cells in mothers after the birth of ABO-incompatible children]. Luboldt W Bibl Haematol; 1969; 32():312-8. PubMed ID: 4981567 [No Abstract] [Full Text] [Related]
16. [Hemolytic disease of the newborn]. Nevanlinna HR Duodecim; 1969; 85(17):986-1003. PubMed ID: 4983455 [No Abstract] [Full Text] [Related]
17. [Effect of the unclamped umbilical cord on the feto-maternal microtransfusion]. Wein N; Schneider I Zentralbl Gynakol; 1970 Aug; 92(34):1113-7. PubMed ID: 4995979 [No Abstract] [Full Text] [Related]
18. [Fetomaternal transfusion in abortion and pregnancy interruptions and Rh-prevention]. Radzuweit H; Krüger B Zentralbl Gynakol; 1975; 97(22):1367-74. PubMed ID: 812290 [TBL] [Abstract][Full Text] [Related]
19. [Problems of immunocompetence in obstetric physiopathology]. Stoppelli I Minerva Ginecol; 1973 Jan; 25(1):1-7. PubMed ID: 4633207 [No Abstract] [Full Text] [Related]
20. [Protective mechanisms in hemolytic disease of the newborn. (Rhesus system)]. Gonzalez Ramos M Ginecol Obstet Mex; 1966; 21(123):469-75. PubMed ID: 4967226 [No Abstract] [Full Text] [Related] [Next] [New Search]